Cite
APA Citation
Fraser, G., Lederman, S., Waldbaum, A., Lee, M., Skillern, L., & Ramael, S. (2019). the neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study. Maturitas, 124, 135–. http://access.bl.uk/ark:/81055/vdc_100083739921.0x00002c